CVS Health Corp
XETRA:CVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CVS Health Corp
XETRA:CVS
|
US |
Intrinsic Value
The intrinsic value of 
CVS Health Corp (CVS) under the Base Case is 70.61 EUR per share.
Compared with the current market price of 66.31 EUR, the stock appears
Undervalued by 6% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What CVS Health Does
CVS Health is a U.S. health care company built around pharmacies, pharmacy benefits, and insurance. It runs retail drugstores and fills prescriptions for walk-in customers, but a big part of its business comes from helping employers, insurers, and government plans manage prescription drug costs through its pharmacy benefit manager, CVS Caremark. It also owns Aetna, which sells health insurance plans to individuals, employers, and Medicare members.
- Headquarters
- United States of America US
- Employees
- 300 000
- IPO date
- Oct 1, 1952
CVS Health has no economic moat
Customers and health plans can choose other pharmacies, insurers and pharmacy-benefit providers, so CVS has no lasting barrier that prevents rivals from winning their business. Familiarity with CVS alone does not make customers stay when other providers offer alternatives.
Read the full moat analysis
Revenue & Expenses Breakdown
CVS Health Corp
Earnings Waterfall
CVS Health Corp
The intrinsic value for CVS Health Corp (CVS) under the Base Case is 70.61 EUR.
Compared with the current market price of 66.31 EUR, the stock appears Undervalued by 6% .